Global Autoinjectors Market

Report ID : 1234 | Published : 2022-08-01 | Pages: | Format: PDF/EXCEL

The Global Autoinjectors Market is estimated to reach over USD 226.37 billion by 2030, exhibiting a CAGR of 19.2% during the forecast period. 

Autoinjectors are pen-like devices that deliver a fixed dose of medication to a patient and are meant to be self-administered. Autoinjectors are gradually becoming the gold standard in the treatment of anaphylaxis, multiple sclerosis, and rheumatoid arthritis. The majority of autoinjectors are spring-loaded, and self-injection is a simple technique. These devices can assist patients in preventing needle stick injuries and lessen needle fear. To improve the simplicity of use and alleviate the anxiety associated with self-administration of intramuscular injections, autoinjector manufacturers are focused on user-centric approaches. The autoinjector market is expected to grow significantly, given the rise in anaphylactic cases. Furthermore, firms' increased R&D efforts to create simple, cost-effective, and innovative technology-based autoinjectors for the treatment of chronic diseases such as rheumatoid arthritis and multiple sclerosis are likely to fuel market growth throughout the forecast period.

On the other hand, there are a variety of chronic conditions that necessitate daily injections. The illness's diversity, on the other hand, requires a combination of autoinjector requirements. The injection capacity, dosage, length, and thickness must be varied for each medication. Different types of autoinjectors result from these factors. The absence of appropriate autoinjectors and product variety may have a negative impact on the autoinjector business. The OEM is untrained in the production of several medications. The major players are addressing these market problems. The market is attempting to meet this problem by conducting additional research.

Market Segmentation:

The Global Autoinjectors Market is segmented on the basis of type, application, and end-user. Based on type, the market is segmented into Disposable Autoinjectors and Reusable Autoinjectors. By application, the market is segmented into Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others. By end-user, the market is segmented as home care settings and Hospitals & Clinics.

Based on application, rheumatoid arthritis is accounted as a significant contributor to the Global Autoinjectors Market.

In 2021, the market for autoinjectors was dominated by rheumatoid arthritis. The high prevalence of this group accounts for its significant share, and the rising prevalence of RA is driving up demand for autoinjectors in this treatment area. Arthritis, RA, gout, lupus, and fibromyalgia affect an estimated 20% of the total population in the United States each year.

Disposable autoinjectors segment witnessed growth at a rapid rate

The autoinjectors market is divided into two types: reusable and disposable autoinjectors. The disposable autoinjectors category held the most significant share of the worldwide autoinjectors market in 2021. Owing to their ease of use and the existence of a built-in glass syringe (which eliminates the need to load the glass syringe manually), disposable autoinjectors are the most popular autoinjectors among patients with poor dexterity or visual impairments.

In the region, the North America Global Autoinjectors Market holds a significant revenue share.

The Asia Pacific market is expected to outperform other regional players during the projected period. In this area, autoinjectors are in high demand. The rising number of diabetics is driving up demand for the product. Furthermore, the healthcare infrastructure is growing at a breakneck speed, and it leads to an increase in the production of autoinjectors. In this region, home care and self-administration of chronic conditions rise. Many patients and their families learn to use autoinjectors for non-urgent situations. The existence of leading autoinjector firms is beneficial to market growth. In the Asia-Pacific area, autoinjectors are constantly evolving and in high demand. Furthermore, an increase in the occurrences of anaphylaxis, rheumatoid arthritis, and other disorders such as anaemia and migraine and future technological developments by firms are likely to propel the market forward.

Competitive Landscape

To keep and grow their customer base, key players are focusing on portable and user-friendly auto-injectors. To protect their brand equity, companies like Mylan N.V. and Eli Lilly and Company are focusing more on user-friendly auto-injectors. New entrants are concentrating their efforts on reaching emerging markets by introducing low-cost auto-injector devices. Some businesses, such as Mylan N.V., Teva Pharmaceuticals, and others, are launching generic versions of cost-effective auto-injectors devices and targeting emerging markets, such as Asia-Pacific, the Middle East, and others, in order to stay competitive and grow in the global Auto-Injectors Market. Some of the key players featured in the auto-injectors market are, Amgen Inc., Antares Pharma, Becton, Dickinson, And Company (BD), ELI LILLY AND COMPANY, Johnson & Johnson, MYLAN N.V., Novartis AG, SHL MEDICAL AG, TEVA Pharmaceutical Industries LTD., YPSOMED AG, ATS Automation Tooling Systems Inc. Owen Mumford Ltd., SHL Group, Oval Medical Technologies Ltd., E3D Elcam Drug Delivery Devices, kaleo, Inc., Crossject, Gerresheimer AG.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Autoinjectors Market Snapshot

Chapter 4. Global Autoinjectors Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. COVID 19 Impact Analysis 2020

Chapter 5. Market Segmentation 1: Type Estimates & Trend Analysis

5.1. Type & Market Share, 2020 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type:

5.2.1. Disposable autoinjectors

5.2.2. Reusable autoinjectors

Chapter 6. Market Segmentation 2: Applications & Trend Analysis

6.1. Applications & Market Share, 2020 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2028 for the following Applications:

6.2.1. Rheumatoid Arthritis

6.2.2. Anaphylaxis

6.2.3. Multiple Sclerosis

6.2.4. Others

Chapter 7. Market Segmentation 3: End-Users & Trend Analysis

7.1. End-Users & Market Share, 2020 & 2028

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:

7.2.1. Home care settings

7.2.2. Hospitals & Clinics

Chapter 8. Autoinjectors Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts Type, 2020-2028

8.1.2. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.1.3. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.1.4. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2028

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2020-2028

8.2.2. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.2.3. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.2.4. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2020-2028

8.3.2. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.3.3. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.3.4. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2020-2028

8.4.2. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.4.3. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.4.4. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts Type, 2020-2028

8.5.2. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.5.3. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.5.4. MEA revenue Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles 

9.2.1. Amgen Inc.

9.2.2. Antares Pharma

9.2.3. Becton, Dickinson, And Company (BD)

9.2.4. ELI LILLY AND COMPANY

9.2.5. Johnson & Johnson

9.2.6. MYLAN N.V.

9.2.7. Novartis AG

9.2.8. SHL MEDICAL AG

9.2.9. TEVA Pharmaceutical Industries LTD.

9.2.10. YPSOMED AG

9.2.11. ATS Automation Tooling Systems Inc.

9.2.12. Owen Mumford Ltd.

9.2.13. SHL Group

9.2.14. Oval Medical Technologies Ltd.

9.2.15. E3D Elcam Drug Delivery Devices

9.2.16. kaleo, Inc.

9.2.17. Crossject

9.2.18. Gerresheimer AG

Segmentation of Global Autoinjectors Market-

By Type-

  • Disposable Autoinjectors
  • Reusable Autoinjectors

By Applications-

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

By End-Users-

  • Home care settings
  • Hospitals & Clinics

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Autoinjectors Market?

USD 226.37 billion by 2030

exhibiting a CAGR of 19.2% during the forecast period.

Our Clients